Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
The Fly
Vertex Pharmaceuticals announces updates across program for povetacicept
1d ago
VRTX
Premium
The Fly
Vertex Pharmaceuticals price target lowered to $438 from $439 at Morgan Stanley
8d ago
VRTX
Premium
Ratings
Vertex Pharmaceuticals: Strong Growth Potential with Promising Product Launches and Robust Pipeline
13d ago
VRTX
Premium
The Fly
Vertex Pharmaceuticals price target raised to $575 from $550 at Citi
16d ago
VRTX
Premium
Ratings
Vertex Pharmaceuticals Hold Rating: Key Factors and Challenges in the IgA Nephropathy Market
20d ago
VRTX
Premium
Ratings
Vertex Pharmaceuticals’ Strategic Acquisition and FDA Breakthrough Designation Boosts Buy Rating
23d ago
VRTX
Premium
The Fly
Morning Movers: CarMax slips following second quarter results
23d ago
C
C
Premium
The Fly
Vertex Pharmaceuticals granted breakthrough therapy designation for povetacicept
23d ago
VRTX
Premium
The Fly
Vertex Pharmaceuticals completes enrollment in IA cohort of AMPLITUDE trial
23d ago
VRTX
Premium
The Fly
Vertex Pharmaceuticals initiates AGLOW study of VX-407
23d ago
VRTX
Premium
The Fly
Leerink ups Vertex Pharmaceuticals to Outperform on stock pullback, solid growth
24d ago
VRTX
Premium
The Fly
Vertex Pharmaceuticals upgraded to Outperform from Market Perform at Leerink
24d ago
VRTX
Premium
Ratings
Vertex Pharmaceuticals: Strong Market Position and Growth Potential Drive Buy Rating
25d ago
VRTX
Premium
The Fly
Vertex Pharmaceuticals announces CASGEVY reimbursement agreement in Italy
1M ago
VRTX
Premium
Ratings
Vertex Pharmaceuticals: Strong Buy Rating Backed by Promising Pipeline and Strategic Positioning
1M ago
VRTX
Premium
Ratings
Vertex Pharmaceuticals Positioned for Growth with FDA Support for Non-Opioid Analgesics
1M ago
VRTX
Premium
Ratings
FDA Draft Guidance Boosts Vertex Pharmaceuticals’ Prospects for Non-Opioid Analgesics
1M ago
VRTX
Premium
Ratings
Vertex Pharmaceuticals: Promising Growth and Strategic Positioning Justify Buy Rating
1M ago
VRTX
Premium
The Fly
Sionna Therapeutics initiated with a Strong Buy at Raymond James
2M ago
SION
VRTX
Premium
The Fly
Vertex Pharmaceuticals initiated with a Market Perform at Raymond James
2M ago
VRTX
Premium
Ratings
Vertex Pharmaceuticals: Strong Prescription Growth and Strategic Initiatives Bolster Buy Rating
2M ago
VRTX
Premium
Ratings
Vertex Pharmaceuticals: Promising Growth with Successful Launch and Strong Pipeline
2M ago
VRTX
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
